Metropolitan Life Insurance CO Novavax Inc Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$4.8 - $7.67 $3,595 - $5,744	749 Added 15.71%	5,518 $26,000
Q2 2023 Aug 10, 2023	BUY	$6.67 - $9.52 $31,809 - $45,400	4,769 New	4,769 $35,000
Q1 2022 May 12, 2022	SELL	$69.73 - $142.9 $349,695 - $716,643	-5,015 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$134.56 - $217.97 $674,818 - $1.09 Million	5,015 New	5,015 $717,000
Q4 2021 Mar 30, 2023	BUY	$134.56 - $217.97 $8,477 - $13,732	63 Added 1.27%	5,015 $717,000
Q4 2021 Feb 15, 2022	BUY	$134.56 - $217.97 $8,477 - $13,732	63 Added 1.27%	5,015 $717,000
Q3 2021 Jun 21, 2023	BUY	$177.8 - $270.58 $880,465 - $1.34 Million	4,952 New	4,952 $1.03 Million
Q3 2021 Mar 30, 2023	SELL	$177.8 - $270.58 $28,803 - $43,833	-162 Reduced 3.17%	4,952 $1.03 Million
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $28,803 - $43,833	-162 Reduced 3.17%	4,952 $1.03 Million
Q2 2021 Jun 21, 2023	BUY	$121.0 - $257.67 $618,794 - $1.32 Million	5,114 New	5,114 $1.09 Million
Q2 2021 Mar 30, 2023	SELL	$121.0 - $257.67 $1.38 Million - $2.93 Million	-11,368 Reduced 68.97%	5,114 $1.09 Million
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $616,858 - $1.31 Million	5,098 Added 31862.5%	5,114 $1.09 Million
Q1 2021 Jun 26, 2023	BUY	$112.98 - $319.93 $1.86 Million - $5.27 Million	16,482 New	16,482 $2.99 Billion
Q1 2021 Mar 30, 2023	SELL	$112.98 - $319.93 $72,872 - $206,354	-645 Reduced 3.77%	16,482 $2.99 Million
Q1 2021 May 14, 2021	SELL	$112.98 - $319.93 $1.93 Million - $5.47 Million	-17,111 Reduced 99.91%	16 $2.99 Million
Q4 2020 Jun 22, 2023	BUY	$78.74 - $139.5 $1.35 Million - $2.39 Million	17,127 New	17,127 $1.91 Million
Q4 2020 Mar 30, 2023	SELL	$78.74 - $139.5 $42,834 - $75,888	-544 Reduced 3.08%	17,127 $1.91 Million
Q4 2020 Feb 16, 2021	SELL	$78.74 - $139.5 $42,834 - $75,888	-544 Reduced 3.08%	17,127 $1.91 Million
Q3 2020 Jun 26, 2023	BUY	$79.44 - $178.51 $1.4 Million - $3.15 Million	17,671 New	17,671 $1.91 Million
Q3 2020 Mar 30, 2023	SELL	$79.44 - $178.51 $1,827 - $4,105	-23 Reduced 0.13%	17,671 $1.91 Million
Q3 2020 Nov 13, 2020	SELL	$79.44 - $178.51 $1,827 - $4,105	-23 Reduced 0.13%	17,671 $1.92 Million
Q2 2020 Jun 26, 2023	BUY	$13.86 - $83.61 $245,238 - $1.48 Million	17,694 New	17,694 $1.47 Million
Q2 2020 Mar 30, 2023	BUY	$13.86 - $83.61 $117,269 - $707,424	8,461 Added 91.64%	17,694 $1.47 Million
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $117,269 - $707,424	8,461 Added 91.64%	17,694 $1.48 Million
Q1 2020 Jul 12, 2023	BUY	$3.93 - $16.0 $36,285 - $147,728	9,233 New	9,233 $125,000
Q1 2020 Mar 30, 2023	BUY	$3.93 - $16.0 $36,285 - $147,728	9,233 New	9,233 $125,000
Q1 2020 May 15, 2020	BUY	$3.93 - $16.0 $36,285 - $147,728	9,233 New	9,233 $125,000

Others Institutions Holding NVAX

# of Institutions

290

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $666M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account